Tumor cells can acquire immunosuppressive factors to directly kill T cells (i.e., FasL, TRAIL) and can overexpress immune checkpoint molecules (ICP), e.g., PD-L1, thereby affecting the functions of activated CD8+ T cells and promoting T cell exhaustion [120]. This evidence concerns the gene CD8A and neoplasm.